This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignees: Biomethodes, Hospices Civils De Lyon. Active years: 2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 5 
1 out of 46 
Years Active: 2014
Title: The Innovations of Didier Saboulard
Introduction
Didier Saboulard is a notable inventor based in Saint Gaudens, France. He has made significant contributions to the field of medicine, particularly in the treatment of hemophilia A. His work focuses on improving human FVIII variants, which are crucial for patients suffering from this condition.
Latest Patents
Didier Saboulard holds a patent for "VIII factors for the treatment of type A hemophilia." This invention relates to improved human FVIII variants that have at least one substitution in the A2 and/or C2 domain. The patent emphasizes the use of these variants in treating hemophilia A, especially in patients with inhibitors. He has 1 patent to his name.
Career Highlights
Throughout his career, Didier has worked with various organizations, including Biomethodes and Hospices Civils De Lyon. His experience in these institutions has allowed him to develop innovative solutions for complex medical challenges.
Collaborations
Didier has collaborated with several professionals in his field, including Jean-Luc Plantier and Marc Delcourt. Their combined expertise has contributed to advancements in hemophilia treatment.
Conclusion
Didier Saboulard's work in the medical field, particularly regarding hemophilia A, showcases his dedication to improving patient outcomes through innovation. His contributions are invaluable to the ongoing research and development in this area.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile